Ignite Creation Date:
2024-05-06 @ 11:04 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03426514
Status:
RECRUITING
Last Update Posted:
2020-02-13
First Post:
2018-01-31
Brief Title:
Three-port Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Study Overview
Official Title:
Single-center Prospective Randomized Controlled Study of the Three-port Laparoscopic Surgery Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Status:
RECRUITING
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to evaluate the short-term and long-term results after three-port laparoscopic surgery for colorectal cancerTLSC compared with conventional laparoscopic surgery for colorectal cancerCLSC
Detailed Description:
At presentsurgical treatments is the main means to cure colorectal cancerCRCThe use of four or more ports has been routine in most laparoscopic colorectal resections Howeverthe drawbacks are the need for added manpower consisting of another assistant to provide counter-traction as well as costs and the unaesthetic effects of additional ports In order to minimize surgical trauma improve cosmesis reduce manpowersingle-incision laparoscopic surgery SILS is attracting increasing attention But it is challenging and highly demanding techniques Becoming proficient at three-port laparoscopic surgery can make the transition to SILS more natureFew studies about three-port laparoscopic surgery for colorectal cancerTLSC have been reported currentlyMore studies especially large-scale randomized controlled trials are needed to establish the best indications for TLSC This is a single-center open-label non-inferiority randomized controlled trial A total of 282 eligible patients will be randomly assigned to TLSC group and CLSC group at a 11 ratio It will provide valuable clinical evidence for the objective assessment of the the feasibility safety and potential benefits of TLSC compared with CLSC
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None